Correction: The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study

Arthritis Res Ther. 2022 Oct 25;24(1):238. doi: 10.1186/s13075-022-02929-0.

Boyoon Choi^{1

2}, Hyun Jin Park¹, Yun-Kyoung Song^{1

3}, Yoon-Jeong Oh⁴, In-Wha Kim¹, Jung Mi Oh⁵

¹ College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
² Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Pocheon-si, Gyeonggi, Republic of Korea.
³ College of Pharmacy, Daegu Catholic University, Gyeongsan-si, Gyeongbuk, Republic of Korea.
⁴ Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon-si, Kangwon, Republic of Korea.
⁵ College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea. [email protected].

No abstract available

Publication types